Related Experiment Video
Updated: Oct 31, 2025

Intravascular Delivery of Biologics to the Rat Kidney
Published on: September 1, 2016
Advancing emergency department-initiated buprenorphine
Kristen Huntley1, Emily Einstein2, Terri Postma3
1Center for the Clinical Trials Network The National Institute on Drug Abuse Bethesda Maryland USA.
Abstract:
Opioids are the main driver of drug overdose deaths in the United States, and there has been a marked increase in opioid-related overdoses during the COVID-19 public health emergency. Many emergency departments (EDs) across the country are implementing ED-initiated buprenorphine programs, and this is a method to address and prevent opioid overdoses. Resources are available to overcome barriers and take action.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drug Delivery: Enteral Route
Depolarizing Blockers: Pharmocokinetics
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Dependence
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

